Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

Rebbeck, Timothy R

Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov 2005 - 7804-10 p. digital

Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

0732-183X

10.1200/JCO.2004.00.8151 doi


Adult
Aged
Breast Neoplasms--genetics
Case-Control Studies
Cohort Studies
Female
Genes, BRCA1
Genes, BRCA2
Genetic Predisposition to Disease
Germ-Line Mutation
Hormone Replacement Therapy
Humans
Incidence
Middle Aged
Ovariectomy
Prospective Studies
Risk Factors
Treatment Outcome